tiprankstipranks
GeneTether Therapeutics, Inc. (TSE:GTTX)
:GTTX
Canadian Market

GeneTether Therapeutics, Inc. (GTTX) Financial Statements

Compare
3 Followers

GeneTether Therapeutics, Inc. Financial Overview

GeneTether Therapeutics, Inc.'s market cap is currently $4.11M. The company's EPS TTM is $-0.025; its P/E ratio is ―; GeneTether Therapeutics, Inc. is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue
Gross Profit----
Operating Income$ -747.28K$ -1.72M$ -1.64M$ -71.96K
EBITDA$ -688.36K$ -1.72M$ -1.64M$ -71.96K
Net Income$ -688.36K$ -1.72M$ -1.64M$ -72.97K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 1.41M$ 1.94M$ 370.45K$ 45.39K
Total Debt$ 0.00$ 0.00$ 0.00$ 122.13K
Net Debt$ -1.36M$ -1.80M$ -179.83K$ 76.75K
Total Liabilities$ 38.59K$ 87.42K$ 213.22K$ 123.16K
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -464.86K$ -1.18M$ -740.26K$ -69.06K
Operating Cash Flow$ -464.86K$ -1.18M$ -740.26K$ -69.06K
Investing Cash Flow
Financing Cash Flow
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

GeneTether Therapeutics, Inc. Debt to Assets

GeneTether Therapeutics, Inc. Cash Flow

GeneTether Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis